Investing Profile

David Allison

InvestorVC
Managing Director at Westlake Village BioPartners
westlakebio.com/team/david-al...San Francisco Bay Area
Photo of David Allison, Managing Director at Westlake Village BioPartners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$100K - $5.0M
$1.5M
10
$820M
CompanyStageDateRound SizeTotal Raised
AllRock Bio
Series ASep 2025$50M
$50M
Borealis Biosciences
Series ADec 2024$30M
$180M
Co-investors: Jerel Davis (Versant Ventures)
Magnetic Insight
Series BJun 2022$17M
Series ADec 2018$13M
$33M
Co-investors: Domenic Merenda (Sand Hill Angels), Nicholas Brathwaite (Celesta), Gregory Baker (Bascom Ventures)
Radionetics Oncology
SeedOct 2021$30M
$30M
Co-investors: Daniel Estes (Frazier Healthcare Partners)
CinCor Pharma
Series BOct 2021$140M
Series AMay 2019$50M
$190M
Co-investors: James Healy (Sofinnova Investments), Maina Bhaman (Soffinova Partners)
Neurogastrx
Series BAug 2021$60M
Series AJan 2018$45M
$110M
Co-investors: Klaus Veitinger (OrbiMed), Aaron Royston (venBio)
Soteria Biotherapeutics
Series AMay 2021$42M
$42M
Co-investors: David Morris
Board Member Borealis Biosciences, Inc.2024 - Present
Board Member Recludix Pharma2023 - Present
Managing Director Westlake Village BioPartners2023 - Present
Board Member AllRock Bio2023 - Present
Board Member Neurogastrx, Inc.2017 - 2025
Board Member Impel Pharmaceuticals2016 - 2024
Board Member Radionetics Oncology2021 - 2023
Board Member (Observer) Inipharm2020 - 2023
Board Member Magnetic Insight, Inc2017 - 2023
Partner 5AM Ventures2016 - 2023
Board Member Portal Instruments2016 - 2023
Board Member CinCor Pharma, Inc.2019 - 2023
Board Member (Observer) Crinetics Pharmaceuticals2015 - 2018
Principal Versant Ventures2014 - 2016
Principal Split Rock Partners2009 - 2014
Senior Associate PTV Healthcare Capital2006 - 2009
Research and Development Engineer SurModics2004 - 2004
NSF Research Fellow Cleveland Clinic2002 - 2002